glipizide has been researched along with Dermatitis Medicamentosa in 2 studies
Glipizide: An oral hypoglycemic agent which is rapidly absorbed and completely metabolized.
glipizide : An N-sulfonylurea that is glyburide in which the (5-chloro-2-methoxybenzoyl group is replaced by a (5-methylpyrazin-2-yl)carbonyl group. An oral hypoglycemic agent, it is used in the treatment of type 2 diabetes mellitus.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tornero, P | 1 |
| De Barrio, M | 1 |
| Baeza, ML | 1 |
| Herrero, T | 1 |
| Adams, BB | 1 |
| Gadenne, AS | 1 |
2 other studies available for glipizide and Dermatitis Medicamentosa
| Article | Year |
|---|---|
Cross-reactivity among p-amino group compounds in sulfonamide fixed drug eruption: diagnostic value of patch testing.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anesthetics, Local; Anti-Infective Agents; Cross Reac | 2004 |
Glipizide-induced pigmented purpuric dermatosis.
Topics: Aged; Drug Eruptions; Glipizide; Humans; Hypoglycemic Agents; Male; Pigmentation Disorders; Purpura | 1999 |